Related references
Note: Only part of the references are listed.New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2
Laura Ragona et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
D. Leali et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
The FGF family: biology, pathophysiology and therapy
Andrew Beenken et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Thrombospondins in cancer
S. Kazerounian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Structure of thrombospondins
C. B. Carlson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
The design, structures and therapeutic potential of protein epitope mimetics
John A. Robinson et al.
DRUG DISCOVERY TODAY (2008)
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain
Barbara Margosio et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Differences between High- and Low-Affinity Complexes of Enzymes and Nonenzymes
Heather A. Carlson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation
Alexandra Esteras-Chopo et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces
James A. Wells et al.
NATURE (2007)
Incorporating dynamics in E. coli dihydrofolate reductase enhances structure-based drug discovery
Michael G. Lerner et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations
Douglas S. Annis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Targeting protein-protein interactions: Lessons from p53/MDM2
Justin K. Murray et al.
BIOPOLYMERS (2007)
Thrombospondin-based antiangiogenic therapy
Xuefeng Zhang et al.
MICROVASCULAR RESEARCH (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Small-molecule targeting of heat shock protein 90 chaperone function: Rational identification of a new anticancer lead
Massimiliano Meli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Exploring one-shot kinetics and small molecule analysis using the ProteOn XPR36 array biosensor
Tsafrir Bravman et al.
ANALYTICAL BIOCHEMISTRY (2006)
Hot-spot mimicry of a cytokine receptor by a small molecule
Christopher D. Thanos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antileukemic activity of shepherdin and molecular diversity of Hsp90 inhibitors
Boglarka Gyurkocza et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Computational sampling of a cryptic drug binding site in a protein receptor: Explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase
Tamara Frembgen-Kesner et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
The gelatin sponge-chorioallantoic membrane assay
Domenico Ribatti et al.
NATURE PROTOCOLS (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Structure of the calcium-rich signature domain of human thrombospondin-2
CB Carlson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Rational design of shepherdin, a novel anticancer agent
J Plescia et al.
CANCER CELL (2005)
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities
F Haviv et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats
M Kvansakul et al.
EMBO JOURNAL (2004)
A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding
BLA Hannah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Thrombospondin modules and angiogenesis
ML Iruela-Arispe et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Modelling of the complex between a 15-residue peptide from mSos2 and the N-terminal SH3 domain of Grb2 by molecular-dynamics simulation
S Calero et al.
CHEMISTRY & BIODIVERSITY (2004)
Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2
B Margosio et al.
BLOOD (2003)
Single-chain antibody fragments derived from a human synthetic phage-display library bind thrombospondin and inhibit sickle cell adhesion
NA Watkins et al.
BLOOD (2003)
Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity -: Crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalenesulfonate
C Fernandez-Tornero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Thrombospondins 1 and 2 function as inhibitors of angiogenesis
LC Armstrong et al.
MATRIX BIOLOGY (2003)
Modulation of protein-protein interactions with small organic molecules
T Berg
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Matricellular proteins: extracellular modulators of cell function
P Bornstein et al.
CURRENT OPINION IN CELL BIOLOGY (2002)
Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor
M Mayer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: Evaluation by two novel binding assays
A Majluf-Cruz et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2000)
Share Paper
